Learn what GHRP-2 studies show about GH release and appetite, where benefit claims exceed the evidence, and what a research COA can establish.

Explore CJC-1295 with DAC research, measured GH and IGF-1 responses, the limits of benefit claims, and how to interpret batch documentation.

Understand ipamorelin research, the animal findings behind selectivity claims, human gastrointestinal trial results, and important safety limitations.

Understand ARA-290 research, findings in sarcoidosis-associated small-fibre neuropathy, evidence limitations and batch documentation.

Explore retatrutide's three receptor targets, a landmark obesity trial, research limitations and how to read documentation for the 60 mg material.

Read about tirzepatide's receptor biology, clinical evidence, the distinction between licensed medicines and research material, and COA checks.

Explore TB-500 research, potential benefits under investigation, the difference from thymosin beta-4 and how to review laboratory documentation.

Understand BPC-157 research, the limits of human evidence and how to review batch documentation. For laboratory research only.